Abstract
Expandable intra-arterial stents are widely used for treating coronary disease. We hypothesized that local gene delivery could be achieved with the controlled release of DNA from a polymer coating on an expandable stent. Our paper reports the first successful transfection in vivo using a DNA controlled-release stent. Green fluorescent protein (GFP) plasmid DNA within emulsion-coated stents was efficiently expressed in cell cultures (7.9% ± 0.7% vs. 0.6% ± 0.2% control, p < 0.001) of rat aortic smooth muscle cells. In a series of pig stent-angioplasty studies, GFP expression was observed in all coronary arteries (normal, nondiseased) in the DNA-treated group, but not in control arteries. GFP plasmid DNA in the arterial wall was confirmed by PCR, and GFP presence in the pig coronaries was confirmed by immunohistochemistry. Thus, DNA-eluting stents are capable of arterial transfection, and could be useful as delivery systems for candidate vectors for gene therapy of cardiovascular diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Serruys, P.W. et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group . N. Engl. J. Med. 331, 489– 495 (1994).
Fischman, D.L. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators . N. Engl. J. Med. 331, 496– 501 (1994).
Moreno, P.R. et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am. J. Cardiol. 84, 462–466, A9 (1999).
Rome, J.J. et al. Adenoviral vector-mediated gene transfer into sheep arteries using a double-balloon catheter. Hum. Gene Ther. 5, 1249– 58 (1994).
Stephan, D.J. et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum. Gene Ther. 7, 1803–1812 (1996).
Chang, M.W. et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518–522 (1995).
Simari, R.D. et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J. Clin. Invest. 98, 225–235 ( 1996).
Simons, M., Edelman, E.R., DeKeyser, J.L., Langer, R. & Rosenberg, R.D. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67– 70 (1992).
Morishita, R., Gibbons, G.H., Kaneda, Y., Ogihara, T. & Dzau, V.J. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene 149, 13–19 (1994).
Chang, M.W., Barr, E., Lu, M.M., Barton, K. & Leiden, J.M. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260–2268 (1995).
Villa, A.E. et al. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ. Res. 76, 505–513 ( 1995).
Cable, D.G. et al. Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries. Cardiovasc. Res. 35, 553–559 (1997).
Sata, M. et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. USA 95, 1213–1217 (1998).
Luo, Z. et al. Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation 99, 1776–1779 (1999).
Sirois, M.G., Simons, M. & Edelman, E.R. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation 95, 669–676 (1997).
Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W. & Levy, R.J. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J Pharm. Sci. 87, 1347–1350 (1998).
Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W. & Levy, R.J. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Colloids and Surfaces B: Biointerfaces 16, 281–290 (1999).
Bonadio, J., Smiley, E., Patil, P. & Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753– 759 (1999).
Shea, L.D., Smiley, E., Bonadio, J. & Mooney, D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551–554 ( 1999).
Roy, K., Mao, H.Q., Huang, S.K. & Leong, K.W. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5, 387–391 (1999).
van der Giessen et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94, 1690–1697 (1996).
Lincoff, A.M., Furst, J.G., Ellis, S.G., Tuch, R.J. & Topol, E.J. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J. Am. Coll. Cardiol. 29, 808–816 (1997).
Yang, R., Lis, J. & Wu, R. Elution of DNA from agarose gels after electrophoresis. Methods Enzymol. 68, 176–182 ( 1979).
Petersen, M., Hamed, A.A., Pedersen, E.B. & Jacobsen, J.P. Bis-intercalation of homodimeric thiazole orange dye derivatives in DNA. Bioconj. Chem. 10, 66–74 (1999).
Felgner, P.L. et al. Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad. Sci. 772, 126–139 (1995).
Sells, M.A. & Chernoff, J. Polymerase chain reaction cloning of related genes. Methods Enzymol. 254, 184–195 (1995).
Acknowledgements
The authors thank Ms. Ginger Nicholson for her efforts in preparing the manuscript. We also thank Dr. Senator Hazelwood and Dr. Kenneth Ryan, Children's Hospital of Philadelphia, for their critical comments. We also thank Mark Bove and Angela Vicencio for technical assistance. We especially thank Dr. George Papandreou of the Cordis Corporation (Johnson & Johnson), for both making stents available, and providing supportive advice and encouragement. This work was supported in part by a research grant from Selective Genetics, Inc. Robert J. Levy is a recipient of an endowed chair from The Children's Hospital of Philadelphia. Crown stents were supplied by Cordis Corporation, Warren, NJ.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klugherz, B., Jones, P., Cui, X. et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 18, 1181–1184 (2000). https://doi.org/10.1038/81176
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/81176
This article is cited by
-
RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations
Journal of Translational Medicine (2017)
-
New methacrylic imidazolium poly(ionic liquid) gel with super swelling capacity for oil-in-water emulsions
Nuclear Science and Techniques (2016)
-
Multilayered Graphene Nano-Film for Controlled Protein Delivery by Desired Electro-Stimuli
Scientific Reports (2015)
-
Design of gene-activated matrix for the repair of skin and cartilage
Polymer Journal (2014)
-
Gene delivery technologies for cardiac applications
Gene Therapy (2012)